CryoCath stock rises on positive news at heart fibrillation conference

MONTREAL (CP) - Stock in CryoCath Technologies Inc. (TSX:CYT) rose Monday as the company reported positive results from trials on its treatment for irregular heart beats. Shares in the Montreal company gained 44 cents, over eight per cent, to trade at $5....More